Evidence map›Paper›PMID 27713240›Full record

ReviewPharmaceuticals (Basel, Switzerland)2010

Hypersensitivity Reactions to Nonsteroidal Anti-Inflammatory Drugs: An Update.

Mario Sánchez-Borges, Fernan Caballero-Fonseca, Arnaldo Capriles-Hulett, Luis González-Aveledo

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Pharmaceuticals (Basel, Switzerland), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07061587 (Developing A Gout Action Plan in Primary Care Setting in Singapore), which is not on this map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.4field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07061587 nanot yet recruitingnot on this mapstarted 2025, after this paper: background citation

Developing A Gout Action Plan in Primary Care Setting in Singapore

TypeinterventionalSponsorSingHealth PolyclinicsRan2025 to 2027Enrolled72ConditionsGout, Hyperuricemia, Gout Flare, Gout ChronicArmsGout action plan
3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 44 citations in OpenAlex.

  1. Article
  2. Anaphylactic shock due to mefenamic acid.Indian journal of pharmacology · 2025
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Mario Sánchez-BorgesAllergy and Immunology Department, Centro Médico Docente La Trinidad, Caracas, Venezuela. sanchezbmario@gmail.com.
Fernan Caballero-FonsecaAllergy and Immunology Department, Centro Médico Docente La Trinidad, Caracas, Venezuela. fercab@cantv.net.
Arnaldo Capriles-HulettAllergy and Immunology Department, Centro Médico Docente La Trinidad, Caracas, Venezuela. arnaldocapriles@gmail.com.
Luis González-AveledoDermatology Service, Centro Médico de Caracas, Caracas, Venezuela. lagaveledo@gmail.com.
Centro Médico Docente La Trinidad · VE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

After beta lactam antibiotics, hypersensitivity reactions to nonsteroidal antiinflammatory drugs are the second cause of hypersensitivity to drugs. Acute manifestations affect the respiratory tract (aspirin exacerbated respiratory disease), the skin (urticaria and angioedema), or are generalized (anaphylaxis). Correct diagnosis and treatment in order to prevent unnecessary morbidity and the potential risk of death from these severe reactions, and to provide proper medical advice on future drug use frequently requires the participation of allergology specialists familiar with these clinical conditions.

Indexed as

anaphylaxisasthmadrug reactionsnon steroidal anti-inflammatory drugs (NSAIDs)urticaria and angioedema

Identifiers

PMID27713240
PMCPMC3991018
OpenAlexW1979977693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.